ENTITY
Shanghai Bio-Heart Biological Technology

Shanghai Bio-Heart Biological Technology (2185 HK)

15
Analysis
Health CareChina
Shanghai Bio-heart Biological Technology Co., Ltd. operates as an innovative interventional cardiovascular device company. The Company produces bioresorbable scaffolds and others. Shanghai Bio-heart Biological Technology also develops renal denervation.
more
Refresh
23 Jun 2021 14:18

Shanghai Bio-Heart (上海百心安) Pre-IPO: Thoughts on Valuation

We provide a pre-money based valuation for Shanghai Bio-heart listing. We forecast the sales for its BRS and RDN respectively. We would re-iterate...

Logo
238 Views
Share
07 Apr 2021 08:38

Pre-IPO Shanghai Bio-Heart Biological Technology - Here Are the Strength and Concerns

The article analyzed Shanghai Bio-Heart Biological in terms of strength (core product, market potential) and concerns (competition, intensive...

Logo
270 Views
Share
28 Mar 2021 09:05

ECM Weekly (28th March 2021) - Bairong, Bilibili HK, Linklogis, Energy Monster, Zhihu, Monde Nissin

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
24 Mar 2021 16:28

Shanghai Bio-Heart (上海百心安) Pre-IPO: Needs a Long Runway

The company's management were mainly from Microport Scientific. It has decent investor backing but we think it is short of blockbuster products.

Logo
573 Views
Share
x